Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-01-01 @ 8:24 PM
Study NCT ID:
NCT00404404
Status:
UNKNOWN
Last Update Posted:
2013-12-18
First Post:
2006-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
Sponsor:
Premiere Oncology
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000515534
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None